Published in Thorax on July 01, 2004
Peripheral Endothelial Function in COPD Patients (endothBPCO) | NCT02593357
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J (2007) 4.27
Statin use reduces decline in lung function: VA Normative Aging Study. Am J Respir Crit Care Med (2007) 2.65
Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med (2010) 2.60
Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One (2012) 2.52
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
Role of transient receptor potential C3 in TNF-alpha-enhanced calcium influx in human airway myocytes. Am J Respir Cell Mol Biol (2006) 2.28
Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 2.20
Ectopic lymphoid tissues and local immunity. Semin Immunol (2008) 2.18
Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax (2005) 2.08
Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax (2005) 2.03
Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 1.94
C-reactive protein and risk of lung cancer. J Clin Oncol (2010) 1.90
Metabolic syndrome biomarkers predict lung function impairment: a nested case-control study. Am J Respir Crit Care Med (2011) 1.86
Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res (2010) 1.79
Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease. Thorax (2005) 1.78
Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia. Am J Respir Crit Care Med (2005) 1.69
Associations between health effects and particulate matter and black carbon in subjects with respiratory disease. Environ Health Perspect (2005) 1.65
Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD. Thorax (2007) 1.62
Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax (2007) 1.62
Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax (2007) 1.61
Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking? Thorax (2011) 1.60
Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 1.57
Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases. Pulm Pharmacol Ther (2013) 1.54
Regulation of airway mucin gene expression. Annu Rev Physiol (2008) 1.53
Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis (2009) 1.52
Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype? Respir Res (2006) 1.51
Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med (2010) 1.50
Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis (2011) 1.47
Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD. Chronic Obstr Pulm Dis (2015) 1.43
Selection of disease-specific biomarkers by integrating inflammatory mediators with clinical informatics in AECOPD patients: a preliminary study. J Cell Mol Med (2012) 1.42
Inflammatory markers and longitudinal lung function decline in the elderly. Am J Epidemiol (2008) 1.42
Pulmonary function is associated with distal aortic calcium, not proximal aortic distensibility. MESA lung study. COPD (2011) 1.41
Prospective study of dietary patterns and chronic obstructive pulmonary disease among US women. Am J Clin Nutr (2007) 1.40
Prospective study of dietary patterns and chronic obstructive pulmonary disease among US men. Thorax (2007) 1.40
Effects of periodontal treatment on exacerbation frequency and lung function in patients with chronic periodontitis: study protocol of a 1-year randomized controlled trial. BMC Pulm Med (2017) 1.38
Factors contributing to muscle wasting and dysfunction in COPD patients. Int J Chron Obstruct Pulmon Dis (2007) 1.37
Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax (2005) 1.35
C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax (2005) 1.33
Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease. Clin Exp Immunol (2006) 1.31
Disruption of p21 attenuates lung inflammation induced by cigarette smoke, LPS, and fMLP in mice. Am J Respir Cell Mol Biol (2008) 1.30
Chronic obstructive pulmonary disease severity and cardiovascular outcomes. Eur J Epidemiol (2006) 1.28
Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study. Respir Res (2010) 1.26
Genetic ablation of NADPH oxidase enhances susceptibility to cigarette smoke-induced lung inflammation and emphysema in mice. Am J Pathol (2008) 1.25
Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2008) 1.24
Systemic inflammation and lung function in young adults. Thorax (2007) 1.23
Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease. Thorax (2012) 1.23
Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland. Respir Med (2009) 1.22
Anemia and performance status as prognostic markers in acute hypercapnic respiratory failure due to chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2013) 1.21
Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk. Thorax (2009) 1.21
Persistent pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS. J Infect Dis (2010) 1.19
Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos Int (2007) 1.19
Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Inflammation (2014) 1.18
COPD and levels of Hsp70 (HSPA1A) and Hsp27 (HSPB1) in plasma and lymphocytes among coal workers: a case-control study. Cell Stress Chaperones (2015) 1.16
Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Lung (2008) 1.16
Cytokine inhibition in the treatment of COPD. Int J Chron Obstruct Pulmon Dis (2014) 1.16
Beyond atrophy: redox mechanisms of muscle dysfunction in chronic inflammatory disease. J Physiol (2011) 1.15
Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD. Drug Des Devel Ther (2010) 1.13
Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients. J Inflamm (Lond) (2010) 1.13
Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial. BMJ Open (2012) 1.13
Changing the burden of COPD mortality. Int J Chron Obstruct Pulmon Dis (2006) 1.11
Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 1.11
Recent advances in pre-clinical mouse models of COPD. Clin Sci (Lond) (2014) 1.10
Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony. Cardiovasc Diabetol (2012) 1.09
Progression of airway dysplasia and C-reactive protein in smokers at high risk of lung cancer. Am J Respir Crit Care Med (2005) 1.09
Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: possible associations with inflammation. Diabetes Care (2010) 1.08
The relationship between small pulmonary vascular alteration and aortic atherosclerosis in chronic obstructive pulmonary disease: quantitative CT analysis. Acad Radiol (2010) 1.07
Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease. Respir Res (2013) 1.06
Domains of chronic stress, lifestyle factors, and allostatic load in middle-aged Mexican-American women. Ann Behav Med (2011) 1.06
IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study. BMC Med Genet (2009) 1.06
The association between COPD and heart failure risk: a review. Int J Chron Obstruct Pulmon Dis (2013) 1.06
Serum levels of nicotinamide N-methyltransferase in patients with lung cancer. J Cancer Res Clin Oncol (2009) 1.05
Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations. Int J Chron Obstruct Pulmon Dis (2011) 1.04
Gender differences in plasma biomarker levels in a cohort of COPD patients: a pilot study. PLoS One (2011) 1.04
Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study. Respir Res (2007) 1.03
Brain-derived neurotrophic factor in cigarette smoke-induced airway hyperreactivity. Am J Respir Cell Mol Biol (2013) 1.03
Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity. PLoS One (2012) 1.03
Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link? Thorax (2006) 1.03
Systemic inflammation, depression and obstructive pulmonary function: a population-based study. Respir Res (2013) 1.03
Social disruption induces lung inflammation. Brain Behav Immun (2009) 1.02
Cytokine and cytokine receptor single-nucleotide polymorphisms predict risk for non-small cell lung cancer among women. Cancer Epidemiol Biomarkers Prev (2009) 1.02
Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease. Clin Dev Immunol (2007) 1.02
Mechanisms of atherothrombosis in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2008) 1.01
Acute-phase proteins: As diagnostic tool. J Pharm Bioallied Sci (2011) 1.00
Leptin receptor polymorphisms and lung function decline in COPD. Eur Respir J (2009) 1.00
Associations between statins and COPD: a systematic review. BMC Pulm Med (2009) 0.99
The relation between dietary intake of individual fatty acids, FEV1 and respiratory disease in Dutch adults. Thorax (2007) 0.99
Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 0.99
Lung function and risk for heart failure among older adults: the Health ABC Study. Am J Med (2011) 0.99
Anti-inflammatory effect of a selective IkappaB kinase-beta inhibitor in rat lung in response to LPS and cigarette smoke. Pulm Pharmacol Ther (2010) 0.98
What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines. Thorax (2007) 0.98
The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year. Int J Chron Obstruct Pulmon Dis (2009) 0.98
Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease. Thromb Res (2009) 0.98
Tumor necrosis factor-alpha serum levels in healthy smokers and nonsmokers. Int J Chron Obstruct Pulmon Dis (2010) 0.98
Gender differences in the association between C-reactive protein, lung function impairment, and COPD. Int J Chron Obstruct Pulmon Dis (2007) 0.98
Inflammation-related effects of diesel engine exhaust particles: studies on lung cells in vitro. Biomed Res Int (2013) 0.98
Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease. Respir Res (2006) 0.97
COPD phenotype description using principal components analysis. Respir Res (2009) 0.97
Frequencies of single nucleotide polymorphisms in genes regulating inflammatory responses in a community-based population. BMC Genet (2007) 0.97
Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences. Int J Chron Obstruct Pulmon Dis (2008) 0.96
Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.96
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med (2001) 27.83
Acute-phase proteins and other systemic responses to inflammation. N Engl J Med (1999) 18.25
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA (1994) 10.46
Chronic obstructive pulmonary disease. N Engl J Med (2000) 8.23
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation (2000) 8.17
Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA (1998) 7.67
Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ (1996) 6.25
Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J (2003) 6.23
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis (2000) 4.88
Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med (1999) 4.72
Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation (2003) 4.63
Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest (2000) 3.96
Systemic effects of chronic obstructive pulmonary disease. Eur Respir J (2003) 3.44
Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM(10)). Am J Respir Crit Care Med (2001) 3.26
Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost (2000) 2.74
C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J (2000) 2.59
Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med (2003) 2.53
Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA (2001) 2.37
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax (1996) 2.33
Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med (2002) 2.32
Cachexia. Ann Intern Med (2000) 2.29
The human bone marrow response to acute air pollution caused by forest fires. Am J Respir Crit Care Med (2000) 2.22
Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation (2002) 2.09
Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1994) 2.06
What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J (2003) 2.02
Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med (1976) 2.00
Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax (2001) 1.94
Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.94
Physiology and pathophysiology of bone remodeling. Clin Chem (1999) 1.91
Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.78
The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.77
Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke (2001) 1.73
Interaction of alveolar macrophages and airway epithelial cells following exposure to particulate matter produces mediators that stimulate the bone marrow. Am J Respir Cell Mol Biol (2002) 1.64
Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol (1991) 1.60
COPD and osteoporosis. Chest (2002) 1.60
Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med (1996) 1.50
Circulating leptin in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.38
Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes. Stat Med (2002) 1.36
Leukocyte count, smoking, and lung function. Am J Med (1984) 1.31
An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD. Respir Med (1998) 1.20
Pulmonary cachexia. Int J Cardiol (2002) 1.15
Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group. Thromb Haemost (1994) 1.13
Associations between white blood cell count, lung function, respiratory illness and mortality: the Busselton Health Study. Eur Respir J (1999) 0.97
Symptoms of chronic bronchitis, haemostatic factors, and coronary heart disease risk. Atherosclerosis (1999) 0.95
Effects of smoking on inflammatory mediators and their relationship to pulmonary dysfunction. Eur J Respir Dis Suppl (1986) 0.92
Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study. BMJ (2013) 2.92
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
Can age and sex explain the variation in COPD rates across large urban cities? A population study in Canada. Int J Tuberc Lung Dis (2011) 2.01
Associations of IL6 polymorphisms with lung function decline and COPD. Thorax (2009) 2.00
Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax (2005) 1.92
Prevalence of asthma, rhinitis and eczema among children in 2 Canadian cities: the International Study of Asthma and Allergies in Childhood. CMAJ (1999) 1.84
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J (2008) 1.76
The natural history of chronic obstructive pulmonary disease. Eur Respir J (2006) 1.66
The association of cardiovascular disease risk factors with abdominal obesity in Canada. Canadian Heart Health Surveys Research Group. CMAJ (1997) 1.61
COPD and cancer mortality: the influence of statins. Thorax (2009) 1.53
Prevalence of asthma and risk factors for asthma-like symptoms in Aboriginal and non-Aboriginal children in the northern territories of Canada. Can Respir J (2008) 1.52
Intravenous rt-PA for acute stroke: comparing its effectiveness in younger and older patients. J Neurol Neurosurg Psychiatry (2005) 1.22
Oxygen saturations less than 92% are associated with major adverse events in outpatients with pneumonia: a population-based cohort study. Clin Infect Dis (2010) 1.21
Observer error and birthweight: digit preference in recording. Public Health (1997) 1.19
Reduced morbidity for elderly patients with a hip fracture after implementation of a perioperative evidence-based clinical pathway. Qual Saf Health Care (2006) 1.17
Steroids in COPD: still up in the air? Eur Respir J (2010) 1.17
The spectrum of neuroendocrine differentiation among gastrointestinal carcinoids: importance of histologic grading, MIB-1, p53, and bcl-2 immunoreactivity. Arch Pathol Lab Med (2000) 1.14
Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter? Eur Respir J (2003) 1.14
Prediction of the rate of decline in FEV(1) in smokers using quantitative Computed Tomography. Thorax (2009) 1.12
Impaired lung function and serum leptin in men and women with normal body weight: a population based study. Thorax (2003) 1.08
Assessment of endotoxin levels in the home and current asthma and wheeze in school-age children. Indoor Air (2008) 1.05
Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link? Thorax (2006) 1.03
A controlled trial of cognitive behavioral treatment of panic in alcoholic inpatients with comorbid panic disorder. Addict Behav (2001) 1.02
Sexually inappropriate behaviour in demented elderly people. Postgrad Med J (2005) 1.02
Total dust and endotoxin in poultry operations: comparison between cage and floor housing and respiratory effects in workers. J Occup Environ Med (2006) 0.99
Prevalence of antinuclear antibodies in a rural population. J Toxicol Environ Health A (1999) 0.99
Respiratory response to endotoxin and dust predicts evidence of inflammatory response in volunteers in a swine barn. Am J Ind Med (2006) 0.95
Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids. Respir Med (2012) 0.95
Positive human health effects of wearing a respirator in a swine barn. Chest (2000) 0.95
A serogrouping scheme for the study of the epidemiology of Bacteroides fragilis. J Med Microbiol (1988) 0.92
Cause and prognosis of acute renal failure in Kuwait: a 2-year prospective study. J Trop Med Hyg (1989) 0.92
The pharmacoepidemiology of COPD: recent advances and methodological discussion. Eur Respir J Suppl (2003) 0.89
Limited agreement between written and video asthma symptom questionnaires. Pediatr Pulmonol (2000) 0.88
Predictors of longitudinal changes in pulmonary function among swine confinement workers. Can Respir J (1999) 0.88
Bone age and growth in fetal alcohol syndrome. Alcohol Clin Exp Res (1998) 0.87
Coupling of CFTR-mediated anion secretion to nucleoside transporters and adenosine homeostasis in Calu-3 cells. J Membr Biol (2003) 0.87
Hydatidiform mole in the elderly: hysterectomy or evacuation? Int J Gynaecol Obstet (1989) 0.86
Physical illness as an outcome of chronic anxiety disorders. Can J Psychiatry (2000) 0.84
Increasing the use of anti-inflammatory agents for acute asthma in the emergency department: experience with an asthma care map. Can Respir J (2008) 0.83
Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast. Thorax (2005) 0.82
Longitudinal estimates of pulmonary function decline in grain workers. Am J Respir Crit Care Med (1994) 0.82
Mosquito bed nets: implementation in rural villages in Zambia and the effect on subclinical parasitaemia and haemoglobin. Trop Doct (2002) 0.80
Effect of age on hospitalized machine-related farm injuries among the Saskatchewan farm population. J Agric Saf Health (2004) 0.80
Health and environment of rural families: results of a Community Canvass survey in the Prairie Ecosystem Study (PECOS). J Agric Saf Health (2000) 0.80
Temporomandibular disorders, headaches, and neck pain after motor vehicle accidents: a pilot investigation of persistence and litigation effects. J Prosthet Dent (1997) 0.80
A model for determining immunogenic relationships between avian infectious bronchitis viruses. Arch Virol (1990) 0.79
Inhaled corticosteroids and survival in COPD patients receiving long-term home oxygen therapy. Respir Med (2005) 0.79
Central sleep apnea and heart failure. N Engl J Med (2000) 0.79
Air quality and respiratory disease in Newcastle, New South Wales. Med J Aust (1992) 0.79
Ineffectiveness of sun awareness posters in dermatology clinics. J Eur Acad Dermatol Venereol (2009) 0.78
Improving presentation skills of family medicine residents: a randomized controlled study. Med Educ (1992) 0.78
The high rate of prevalence of CT-detected basal ganglia calcification in neuropsychiatric (CNS) brucellosis. Acta Neurol Scand (1987) 0.77
In vitro production of tumor necrosis factor-alpha by human monocytes stimulated with lipopolysaccharide is positively correlated with increased blood monocytes after exposure to a swine barn. J Toxicol Environ Health A (2008) 0.77
A comparison of TMD patients with or without prior motor vehicle accident involvement: treatment and outcomes. J Orofac Pain (1997) 0.77
Predictors of onset of wheezing in grain elevator workers. Can Respir J (1998) 0.77
Can inhaled steroids mend a broken heart in chronic obstructive pulmonary disease? Eur Respir J (2005) 0.77
Factors affecting work-related shoulder pain. Occup Med (Lond) (2012) 0.76
Selective antegrade cerebral perfusion during aortic arch surgery confers survival and neuroprotective advantages. J Thorac Cardiovasc Surg (2010) 0.76
Use of gastrointestinal and respiratory illness hospitalization rates as indicators of different social influences. Can J Public Health (1993) 0.75
Theophylline therapy for near-fatal Cheyne-Stokes respiration. Ann Intern Med (1999) 0.75
Slaying the CVD dragon with steroids. Eur Respir J (2010) 0.75
Inhaled corticosteroids and mortality in COPD. Thorax (2006) 0.75
Effect of impact and injury characteristics on post-motor vehicle accident temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1998) 0.75
Evaluation of associations between feed withdrawal and other management factors with Salmonella contamination of broiler chickens at slaughter in Alberta. J Food Prot (2009) 0.75
Preoperative prognosis for cancer of the vulva. Obstet Gynecol (1981) 0.75
Comparison between a short and a conventional blade periodontal curet: an in vitro study. J Clin Periodontol (1999) 0.75
Excess body fat distribution and glucose homeostasis in obese Arab women. Diabet Med (1988) 0.75
Chronic bronchitis in Aboriginal people--prevalence and associated factors. Chronic Dis Inj Can (2013) 0.75
A comparison of TMD patients with or without prior motor vehicle accident involvement: initial signs, symptoms, and diagnostic characteristics. J Orofac Pain (1997) 0.75
Evaluation of a new periodontal curet. An in vitro study. J Clin Periodontol (1992) 0.75
The haematocrit value in diabetic patients with ischaemic stroke. Diabetes Res (1989) 0.75
[Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease]. Rev Port Pneumol (2006) 0.75
Mental health in Alberta grain farmers using pesticides over many years. Occup Med (Lond) (2012) 0.75